Kassia Burini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kassia Burini has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Ana Cristina Simoes-E-Silva
Department of Pediatrics, Unit of Pediatric Nephrology, Interdisciplinary Laboratory of Medical Investigation, Faculty of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil
1 shared publication - Laura Gregório Pires
Medicine School, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil
1 shared publication - Roberta da Silva Filha
Faculty of Medicine, Interdisciplinary Laboratory of Medical Investigation, Federal University of Minas Gerais (UFMG), Belo Horizonte, MG, Brazil
1 shared publication - Sérgio Veloso Brant Pinheiro
Universidade Federal de Minas Gerais Faculdade de Medicina
1 shared publication
Latest Publications
- 1 November 2022
- Published by Bentham Science Publishers Ltd. in Current Pediatric Reviews
- Vol. 18 (4) , 251-264
Idiopathic Nephrotic Syndrome in Pediatrics: An Up-to-date
Background: Idiopathic or Primary Nephrotic Syndrome (INS) is a common glomerular disease in pediatric population, characterized by proteinuria, edema and hypoalbuminemia with var-iable findings in renal histopathology.Objective: This review aims to summarize current data on the etiopathogenesis diagnosis, protocols of treatment and potential therapeutic advances in INS.Methods: This narrative review searched for articles on histopathology, physiopathology, genetic causes, diagnosis and treatment of INS in pediatric patients. The databases evaluated were PubMed and Scopus.Results: INS is caused by an alteration in the permeability of the glomerular filtration barrier with unknown etiology. There are several gaps in the etiopathogenesis, response to treatment and clinical course of INS that justify further investigation. Novel advances include the recent understanding of the role of podocytes in INS and the identification of genes associated with the disease. The role of immune system cells and molecules has also been investigated. The diagnosis relies on clinical find-ings, laboratory exams and renal histology for selected cases. The treatment is primarily based on steroids administration. In case of failure, other medications should be tried. Recent studies have al-so searched for novel biomarkers for diagnosis and alternative therapeutic approaches.Conclusion: The therapeutic response to corticosteroids still remains the main predictive factor for the prognosis of the disease. Genetic and pharmacogenomics tools may allow the identification of cases not responsive to immunosuppressive medications.
- 1 November 2022
- Published by Bentham Science Publishers Ltd. in Current Pediatric Reviews
- Vol. 18 (4) , 251-264
Idiopathic Nephrotic Syndrome in Pediatrics: An Up-to-date
Background: Idiopathic or Primary Nephrotic Syndrome (INS) is a common glomerular disease in pediatric population, characterized by proteinuria, edema and hypoalbuminemia with var-iable findings in renal histopathology.Objective: This review aims to summarize current data on the etiopathogenesis diagnosis, protocols of treatment and potential therapeutic advances in INS.Methods: This narrative review searched for articles on histopathology, physiopathology, genetic causes, diagnosis and treatment of INS in pediatric patients. The databases evaluated were PubMed and Scopus.Results: INS is caused by an alteration in the permeability of the glomerular filtration barrier with unknown etiology. There are several gaps in the etiopathogenesis, response to treatment and clinical course of INS that justify further investigation. Novel advances include the recent understanding of the role of podocytes in INS and the identification of genes associated with the disease. The role of immune system cells and molecules has also been investigated. The diagnosis relies on clinical find-ings, laboratory exams and renal histology for selected cases. The treatment is primarily based on steroids administration. In case of failure, other medications should be tried. Recent studies have al-so searched for novel biomarkers for diagnosis and alternative therapeutic approaches.Conclusion: The therapeutic response to corticosteroids still remains the main predictive factor for the prognosis of the disease. Genetic and pharmacogenomics tools may allow the identification of cases not responsive to immunosuppressive medications.